Innovative Product Launches Ascensia Diabetes Care's recent introduction of the Eversense 365 CGM system, the only long-term CGM providing a year of continuous monitoring, presents a significant opportunity to target healthcare providers and clinics seeking advanced, reliable diabetes management solutions.

Strategic Market Expansion With active marketing campaigns and partnerships in the U.S. alongside expansion into Poland and collaborations with local pharmacies, Ascensia is increasing its market reach, opening doors for sales teams to engage with new regions and healthcare networks.

Strong Industry Presence Positioned alongside major competitors like Dexcom and Insulet, Ascensia's focus on innovative glucose monitoring devices highlights a key opportunity to differentiate and position complementary or integrated solutions to health institutions and diabetes care providers.

Growing Corporate Footprint Recognition as a Great Place to Work and ongoing partnerships with healthtech firms like Fitterfly and SNAQ indicate a robust corporate culture and network, which can facilitate introductions and long-term business relationships in the healthcare technology sector.

Financial Strength and Stability With a revenue range of $500 million to 1 billion and a dedicated focus on diabetes care innovation, Ascensia has the financial backing to invest in new product development and sales channels, providing opportunities for partners seeking to expand within the medical device and diabetes management markets.